CompsDesk

HARTE HANKS, INC. (HHS) — benchmarks from SEC filings

Latest fiscal year 2025 · computed deterministically from XBRL 10-K data · coverage 100%

$160MRevenue FY2025
-13.9%Revenue growth
0.2%Operating margin
-0.5%Net margin
-2.8%FCF margin

In fiscal 2025, HARTE HANKS, INC. reported revenue of $160M, down 13.9% year over year. Operating margin was 0.2% and net margin -0.5%, on a free-cash-flow margin of -2.8% with capital expenditure at 1.7% of revenue. Every figure is computed directly from HHS's SEC XBRL 10-K filing — deterministic, with no estimates.

Fiscal yearRevenueOp marginNet margin
FY2025$160M0.2%-0.5%
FY2024$185M1.1%-16.4%
FY2023$191M1.8%-0.8%
FY2022$206M7.3%17.8%
FY2021$195M3.9%7.7%

How does HHS compare against its actual peer set?

A CompsDesk subscription covers unlimited benchmark packs on any covered company: up to 19 metrics (6 core guaranteed) × up to 5 fiscal years × up to 12 chosen peers, percentile placement, the subject's figures cited to their SEC tag, form and period with every company identified by its CIK, PDF-ready HTML + CSV, generated on demand.

See subscription plans →   or see a free sample first

Related in the same sector: ABM · ACIW · ACN · ACVA · ADBE · ADMQ

Source: SEC EDGAR XBRL (10-K filings), latest filed values. "n/a" = not disclosed under mapped tags — never estimated. Informational benchmarking, not investment advice. © CompsDesk / Sam Arora.